What is it about?

Fluorescent tracers can help surgeons identify cancer during surgery, but not all tumors produce the same signal. We studied 97 tissue samples from 29 patients with colorectal cancer or liver metastases using SGM-101, a tracer targeting the CEA protein. We found that fluorescence contrast varied between tumors and was associated with different tissue characteristics depending on tumor location. Our findings highlight that tumor visibility depends on more than the targeted protein alone.

Featured Image

Why is it important?

Fluorescence-guided surgery may help surgeons distinguish cancer from healthy tissue, but its effectiveness depends on how clearly tumors can be seen. Our study suggests that the factors associated with fluorescence contrast differ between primary colorectal tumors and liver metastases. While CEA expression was associated with contrast in liver metastases, tissue composition was associated with contrast in primary tumors. These findings highlight the importance of considering both tumor biology and surrounding tissue when interpreting fluorescence signals. This knowledge may help guide future research aimed at improving fluorescence-guided surgery.

Perspectives

What interested me most about this research was understanding the biological factors behind differences in fluorescence between tumors and even within the same tumor. Although fluorescence-guided surgery is designed to improve tumor visualization, the relationship between fluorescence intensity and the underlying tissue biology is not always straightforward. For me, this study was an opportunity to explore that relationship more closely and to look beyond fluorescence measurements alone. I hope our findings encourage further investigation into how tumor characteristics and the surrounding tissue influence the performance of targeted imaging agents, ultimately contributing to a better understanding of fluorescence-guided surgery.

Ana Matoshi
Leiden University Medical Center

Read the Original

This page is a summary of: Variation in SGM-101 fluorescence is associated with tumor biology in primary colorectal cancer and colorectal liver metastases, Surgical Oncology, December 2026, Elsevier,
DOI: 10.1016/j.suronc.2026.102571.
You can read the full text:

Read

Contributors

The following have contributed to this page